(MedPage Today) — DENVER — The four-component meningococcal serogroup B vaccine (4CMenB; Bexsero) did not reduce gonorrhea incidence in high-risk men who have sex with men, according to a randomized trial.
The incidence rate ratio [IRR] of…
Source link : https://www.medpagetoday.com/meetingcoverage/croi/120070
Author :
Publish date : 2026-02-26 22:16:00
Copyright for syndicated content belongs to the linked Source.
